Structural and Valvular

Routine Use of Edoxaban Post-TAVR in Patients Without an Indication for Anticoagulation Does Not Significantly Reduce Valve Thrombosis or Stroke

Self-Expanding TAVR in Intermediate-Risk Patients Non-Inferior to SAVR at 5 Years

Randomized trial of plug-based closure device versus suture-based closure after TAVR shows mixed results.

Self-expanding TAVR in intermediate risk patients non-inferior to SAVR at 5 years. 

Two-year economic outcomes from a randomized trial of TAVR vs. SAVR in patients at low surgical risk.